Oral environment and cancer
© The Author(s) 2016
Received: 14 March 2016
Accepted: 19 April 2016
Published: 1 August 2016
Cancer is now the leading cause of death in Japan. A rapid increase in cancer mortality is expected as Japan is facing a super-aged society. Many causes of cancer are known to be closely linked to life style factors, such as smoking, drinking, and diet. The oral environment is known to be involved in the pathogenesis and development of various diseases such as bronchitis, pneumonia, diabetes, heart disease, and dementia. Because the oral cavity acts as the bodily entrance for air and food, it is constantly exposed to foreign substances, including bacteria and viruses. A large number of bacteria are endemic to the oral cavity, and indigenous oral flora act to prevent the settlement of foreign bacteria. The oral environment is influenced by local factors, including dental plaque, tartar, teeth alignment, occlusion, an incompatible prosthesis, and bad lifestyle habits, and systemic factors, including smoking, consumption of alcohol, irregular lifestyle and eating habits, obesity, stress, hormones, and heredity. It has recently been revealed that the oral environment is associated with cancer. In particular, commensal bacteria in the oral cavity are involved in the development of cancer. Moreover, Candida, human papilloma virus and Epstein-Barr virus as well as commensal bacteria have been reported to be associated with the pathogenesis of cancer. In this review, we introduce recent findings of the correlation between the oral environment and cancer.
KeywordsCancer Oral environment Bacteria Candida Human papilloma virus Epstein-Barr virus
During 2012, approximately 14.1 million new cases of human cancer were reported globally . In Japan, the estimated number of cancer deaths during 2014 was approximately 367,000 . Regarding the age-specific causes of death, during 2013, cancer was the leading cause of death among 40–89 years in Japan . Tobacco use accounts for approximately 22 % of cancer deaths , followed by obesity, a poor diet, lack of physical activity, and consumption of alcohol, which collectively account for 10 % of cancer deaths [3, 4]. Other factors include infections, exposure to ionizing radiation, and environmental pollutants . Thus, various causes of cancer are known to be closely involved in lifestyle choices, such as smoking, drinking, and diet.
Oral bacteria and cancer
The link between oral infections and adverse systemic conditions has attracted a great deal of attention in the dental and medical fields. A major consequence of the systemic spread of oral commensals and pathogens to distant body sites has been the disruption of immune surveillance and homeostasis, resulting in the promotion or acceleration of pathogenic processes. Oral bacteria are involved in systemic infections and inflammation such as cardiovascular disease, adverse pregnancy outcomes, rheumatoid arthritis, aspiration pneumonia, inflammatory bowel disease, organ inflammations, and cancer (Fig. 1). Cumulative studies have revealed that oral bacteria are involved in the initiation or progression of certain cancers. Chronic or dysregulated inflammation contributes to tumor development, partly through the modulation of the tumor microenvironment . Epidemiological studies have shown that the risk of cancer is increased in people with periodontal disease or tooth loss caused by oral bacteria . Oral diseases, including periodontitis, have been related to the risk of oral and gastrointestinal cancers, such as oral, esophageal, gastric and pancreatic cancers [13, 14]. Although the underlying mechanism for the associations between oral health status and cancers are not completely understood, it has been reported that Fusobacterium nucleatum and Porphyromonas gingivalis are involved in cancer development.
Accumulated evidence has shown strong correlations between a number of chronic periodontal bacteria containing Prevotella, Porphyromonas and Streptococcus spp. and orodigestive cancer, including oral squamous cell carcinoma and pancreatic cancer [25–31]. P. gingivalis have an abundance of virulence factors and can be present in periodontal pockets. P. gingivalis has a major disruptive effect on local immune responses in the periodontal area . Moreover, it can survive within the oral epithelial tissues and can evade the host immune response [32–37]. In vitro studies have demonstrated that i) P. gingivalis strains can induce the expression of the B7-H1 and B7-DC receptors in oral cancer cells, which might facilitate immune evasion by oral cancers  and ii) P. gingivalis activates the ERK1/2-Ets1, p38/HSP27, and PAR2/NF-kB pathways to induce proMMP9 expression, after which the proenzyme is activated by gingipains to promote cellular invasion of oral cancer cells . In primary cultures of gingival epithelial cells, P. gingivalis is strongly antiapoptotic and can suppress chemically induced apoptosis via activation of the Jak1/Akt/Stat3 signaling pathway [40, 41], suggesting that the antiapoptotic effect of P. gingivalis may be involved in carcinogenesis. Thus, both P. gingivalis and F. nucleatum are involved in cancer progression via activation of cell signaling and/or facilitating immune evasion. However, the possible link between oral bacterium and cancer development remains to be investigated in molecular detail.
Viral and Candida infection and cancer
Tobacco and alcohol are considered as major risk factors for cancer; however, viral and candidal infection is increasingly being identified to play significant roles in cancer development . Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that induce hyperproliferative lesions in epithelial tissues [43, 44]. More than 100 types of HPV have been identified. Among them, high-risk HPV types, including HPV type 16 (HPV-16), HPV-18, HPV-31, HPV-33, and HPV-42, induce lesions in the genital tract that can progress to malignancy [44–46]. HPV is the most common sexually transmitted viral infection and is well-known as the causative agent of cervical cancer. HPV infection has also been detected in the oral cavity. A large number of studies have demonstrated a 2–3-fold increase in the prevalence of HPV-driven oropharyngeal squamous cell carcinoma over the last three decades, particularly in North America and northern Europe [47–49]. Moreover, a recent review found that many studies have identified a high proportion of oral cancer with detectable HPV DNA . Although the underlying reasons remain poorly understood, changes in sexual behavior, decreased rates of tonsillectomy performed in the pediatric population since the 70s, and progress in the diagnostic work-up and HPV testing assays have been proposed as the reasons [51–55]. Considering current trends, it is estimated that high-risk HPVs, such as HPV16 and HPV18, cause premalignant lesions [54, 55]. In the high-risk HPV types, E6 and E7 have been shown to function as oncoproteins [56, 57]. E6 and E7 oncoproteins are the key drivers of tumorigenesis by inactivating the tumor suppressors pRb and p53 .
Epstein–Barr virus (EBV) causes infectious mononucleosis and oral hairy leukoplakia, and is associated with various types of lymphoid and epithelial malignancies. During 1964, Epstein et al. determined the causative agent of Burkitt’s lymphoma to be a previously unknown member of the herpes family of viruses, later termed as EBV . Burkitt lymphoma can be classified into three forms, which differ in geographic distribution and EBV association: endemic, sporadic, and HIV associated Burkitt lymphoma. Among them, endemic Burkitt lymphoma is associated with EBV in over 95 % cases . Endemic Burkitt lymphoma is predominant in the equatorial belt of Africa and other parts of the world where malaria is hyperendemic [60–63]. On the other hand, although controversial, lymphoepithelial carcinoma and nasopharyngeal carcinoma may also be associated with EBV [64–68]. The association between lymphoepithelial carcinoma and EBV appears to differ according to geographic areas, race, and affected organs. In general, the association of lymphoepithelial carcinoma with EBV is strong in the head and neck region, whereas it is relatively weak at other sites. Moreover, the association is strong in East Asia and relatively weak in western countries. To a great extent, EBV-mediated disruption of cell growth checkpoints relies on direct modulation of cytokine receptor signaling mechanisms and alterations in the expression levels of various cytokines . Moreover, EBV is associated with aggressive types of oral tumors, particularly in immunosuppressed patients . Thus, EBV infection of the oral cavity is also associated with certain types of cancer. However, the pathogenesis of these tumors remains unclear.
Oropharyngeal candidiasis is an opportunistic infection primarily caused by Candida albicans, a ubiquitous fungal organism that is part of the normal microflora of the gastrointestinal and reproductive tracts. Candida species can be isolated as a commensal organism from the oral cavity in up to 80 % healthy individuals . Depending on the host defense mechanisms or oral microenvironment, Candida species can transform from a harmless commensal species to pathogenic organisms causing oral mucosal infection [72, 73]. Candida-associated denture stomatitis affects more than 25 % denture wearers , and up to 90 % HIV+ patients have had at least one episode of oropharyngeal candidiasis . When dealing with a hyperplastic epithelial lesion of the oral mucosa in which presence of C. albicans is demonstrated, it is referred to by many as Candida-associated leukoplakia or others prefer the term “hyperplastic candidiasis.” Chronic hyperplastic candidiasis showed a higher rate of malignant transformation on follow-up . Animal studies have shown that Candida can cause epithelial hyperplasia and cellular atypia . Strains of Candida can produce carcinogenic nitrosamine, N-nitrosobenzylmethylamine . Thus certain strains of Candida play a key role in oncogene formation and initiation of cancer development [77–79]. However, the possible role of Candida in malignant transformation remains still unclear.
Many of the causes of cancer are known to be closely linked to lifestyle factors, such as smoking, drinking, and diet. The oral environment is associated with the cause of various diseases, including cancer. The oral environment is influenced by various factors, including local and systemic factors. In the current review, in particular, we introduced the involvement of oral bacteria, funguses, and viruses in the development of cancer. During recent years, the role of oral care for the management of general health has been found to be important within the fields of medical and nursing care. Therefore, oral care for the management of the oral environment can be important for prevention of cancer.
The authors thank Dr. Shinji Oikawa and Dr. Hiroyuki Kamiya, Organizers of The Open Symposium of the JEMS in 2015, and the Japanese Environmental Mutagen Society. The authors would like to thank Enago (www.enago.jp) for the English language review.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- World Health Organization. The global and regional burden of cancer. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. IARC Nonserial Publication. Chapter 1.1.
- Center for Cancer Control and Information Services, National Cancer Canter, Japan: http://ganjoho.jp/reg_stat/statistics/index.html. 2014. Accessed in February 2016.
- “Cancer Fact sheet No.297”. World Health Organization: http://www.who.int/mediacentre/factsheets/fs297/en/(2014). Accessed in in February 2016.
- “Obesity and Cancer Risk”. National Cancer Institute: http://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet#q3 (2012). Accessed in in February 2016.
- Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25:2097–116.View ArticlePubMedPubMed CentralGoogle Scholar
- Jane ES, Desrocher J. “Oral ecology.” Technology Review (00401692) 100.1 (Jan. 1997): 48. Academic search premier. EBSCO. Provo, UT: Brigham Young University; 2008.Google Scholar
- Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: The polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409–19.View ArticlePubMedPubMed CentralGoogle Scholar
- Abiko Y, Sato T, Mayanagi G, Takahashi N. Profiling of subgingival plaque biofilm microflora from periodontally healthy subjects and from subjects with periodontitis using quantitative real-time PCR. J Periodontal Res. 2010;45:389–95.View ArticlePubMedGoogle Scholar
- Preza D, Olsen I, Willumsen T, Boches SK, Cotton SL, Grinde B, et al. Microarray analysis of the microflora of root caries in elderly. Eur J Clin Microbiol Infect Dis. 2009;28:509–17.View ArticlePubMedPubMed CentralGoogle Scholar
- Meurman J. Oral microbiota and cancer. J Oral Microbiol. 2010;2:1–10.View ArticleGoogle Scholar
- Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med. 2006;79:123–30.PubMedPubMed CentralGoogle Scholar
- Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–20.View ArticlePubMedGoogle Scholar
- Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19:895–907.View ArticlePubMedPubMed CentralGoogle Scholar
- Fitzpatrick SG, Katz J. The association between periodontal disease and cancer: a review of the literature. J Dent. 2010;38:83–95.View ArticlePubMedGoogle Scholar
- Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Op Microb. 2015;23:141–7.View ArticleGoogle Scholar
- Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, et al. Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586. J Bacteriol. 2002;184:2005–18.View ArticlePubMedPubMed CentralGoogle Scholar
- Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 2011;13:25–36.PubMedGoogle Scholar
- Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299–306.View ArticlePubMedPubMed CentralGoogle Scholar
- Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 2012;7:e39743.View ArticlePubMedPubMed CentralGoogle Scholar
- McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One. 2013;8:e53653.View ArticlePubMedPubMed CentralGoogle Scholar
- Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-Cadherin/ß-Catenin signaling via its FadA Adhesin. Cell Host Microbe. 2013;14:195–206.View ArticlePubMedPubMed CentralGoogle Scholar
- Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–15.View ArticlePubMedPubMed CentralGoogle Scholar
- Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42:344–55.View ArticlePubMedPubMed CentralGoogle Scholar
- Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34:304–8.View ArticlePubMedGoogle Scholar
- Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005;3:27.View ArticlePubMedPubMed CentralGoogle Scholar
- Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012;33:1055–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23:399–404.View ArticlePubMedPubMed CentralGoogle Scholar
- Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci. 2011;3:209–15.View ArticlePubMedPubMed CentralGoogle Scholar
- Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013;62:1764–70.View ArticlePubMedGoogle Scholar
- Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis. 2013;34:2193–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Yao L, Jermanus C, Barbetta B, Choi C, Verbeke P, Ojcius DM, et al. Porphyromonas gingivalis infection sequesters pro-apoptotic Bad through Akt in primary gingival epithelial cells. Mol Oral Microbiol. 2010;25:89–101.View ArticlePubMedPubMed CentralGoogle Scholar
- Yilmaz O. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology. 2008;154:2897–903.View ArticlePubMedPubMed CentralGoogle Scholar
- Yilmaz O, Yao L, Maeda K, Rose TM, Lewis EL, Duman M, et al. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell Microbiol. 2008;10:863–75.View ArticlePubMedPubMed CentralGoogle Scholar
- Yilmaz O, Sater AA, Yao L, Koutouzis T, Pettengill M, Ojcius DM. ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by Porphyromonas gingivalis. Cell Microbiol. 2010;12:188–98.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh A, Wyant T, Anaya-Bergman C, Aduse-Opoku J, Brunner J, Laine ML, et al. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infect Immun. 2011;79:4533–42.View ArticlePubMedPubMed CentralGoogle Scholar
- Choi CH, Spooner R, DeGuzman J, Koutouzis T, Ojcius DM, Yilmaz O. Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor/NADPH-oxidase signaling and contributes to persistence. Cell Microbiol. 2013;15:961–76.View ArticlePubMedPubMed CentralGoogle Scholar
- Groeger S, Domann E, Gonzales JR, Chakraborty T, Meyle J. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology. 2011;216:1302–10.View ArticlePubMedGoogle Scholar
- Inaba H, Sugita H, Kuboniwa M, et al. (2013) Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol. 2013;16:131–45.View ArticlePubMedPubMed CentralGoogle Scholar
- Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, Handfield M, et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell Microbiol. 2007;9:1997–2007.View ArticlePubMedPubMed CentralGoogle Scholar
- Yilmaz O, Jungas T, Verbeke P, Ojcius DM. Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect Immun. 2004;72:3743–51.View ArticlePubMedPubMed CentralGoogle Scholar
- Bouquot NDA. Oral and maxillofacial pathology. 2nd ed. Philadelphia: Saunders Elsevier; 2002. p. 5055–08.Google Scholar
- Zur Hausen H, De Villiers EM. Human papillomaviruses. Annu Rev Microbiol. 1994;48:427–47.View ArticlePubMedGoogle Scholar
- Howley PM. Papillomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fundamental virology. Philadelphia: Lippincott-Raven; 1996. p. 947–78.Google Scholar
- Laimins LA. The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis. 1993;2:74–86.PubMedGoogle Scholar
- Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–8.View ArticlePubMedGoogle Scholar
- Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301.View ArticlePubMedPubMed CentralGoogle Scholar
- Chenevert J, Chiosea S. Incidence of human papillomavirus in oropharyngeal squamous cell carcinomas: now and 50 years ago. Hum Pathol. 2012;43:17–22.View ArticlePubMedGoogle Scholar
- Garnaes E, Kiss K, Andersen L, Therkildsen MH, Franzmann MB, Filtenborg-Barnkob B, et al. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000–2010: the largest registry-based study to date. Int J Cancer. 2015;136:2196–203.View ArticlePubMedGoogle Scholar
- Mirghani H, Amen F, Moreau F, Lacau SGJ. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral Oncol. 2015;51:229–36.View ArticlePubMedGoogle Scholar
- D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control. 2000;11:489–95.View ArticlePubMedGoogle Scholar
- Chenevert J, Seethala RR, Barnes EL, Chiosea SI. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970. Laryngoscope. 2012;122:793–6.View ArticlePubMedGoogle Scholar
- Zur HH. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.View ArticleGoogle Scholar
- Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30 Suppl 5:F55–70.View ArticlePubMedGoogle Scholar
- Huibregtse JM, Beaudenon SL. Mechanism of HPV E6 proteins in cellular transformation. Semin Cancer Biol. 1996;7:317–26.View ArticlePubMedGoogle Scholar
- Kubbutat MH, Vousden KH. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies. Semin Virol. 1996;7:295–304.View ArticleGoogle Scholar
- Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10:550–60.View ArticlePubMedGoogle Scholar
- Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;15:702–3.View ArticleGoogle Scholar
- Ferry JA. Burkitt’s lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11:375–83.View ArticlePubMedGoogle Scholar
- Pattle SB, Farrell PJ. The role of Epstein–Barr virus in cancer. Expert Opin Biol Ther. 2006;6:1193–205.View ArticlePubMedGoogle Scholar
- van den Bosch CA. Is endemic Burkitt’s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol. 2004;5:738–46.View ArticlePubMedGoogle Scholar
- Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009–20.View ArticlePubMedGoogle Scholar
- Cerilli LA, Holst VA, Brandwein MS, Stoler MH, Mills SE. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol. 2001;25:156–63.View ArticlePubMedGoogle Scholar
- Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology. 1997;31:75–82.View ArticlePubMedGoogle Scholar
- Tardío JC, Cristóbal E, Burgos F, Menárguez J. Absence of EBV genome in lymphoepithelioma-like carcinomas of the larynx. Histopathology. 1997;30:126–8.View ArticlePubMedGoogle Scholar
- Tsai CC, Chen CL, Hsu HC. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol. 1996;27:258–62.View ArticlePubMedGoogle Scholar
- Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson Jr HF, Cooper PH, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol. 1989;13:625–31.View ArticlePubMedGoogle Scholar
- Young LS, Dawson CW, Eliopoulos AG. The expression and function of Epstein-Barr virus encoded latent genes. Mol Path. 2000;53:238–47.View ArticleGoogle Scholar
- Leong IT, Fernandes BJ, Mock D. Epstein–Barr virus detection in non- Hodgkin’s lymphoma of the oral cavity: an immunocytochemical and in situ hybrid-ization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:184–93.View ArticlePubMedGoogle Scholar
- Odds FC. Candida and candidosis: a review and bibliography. London, UK: Bailliere Tindale; 1988.Google Scholar
- Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents. 2008;32 Suppl 2:S87–91.View ArticlePubMedGoogle Scholar
- Marol S, Yücesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses. 2008;51:40–9.PubMedGoogle Scholar
- Lamy M, Mojon P, Kalykakis G, Legrand R, Budtz-Jorgensen E. Oral status and nutrition in the institutionalized elderly. J Dent. 1999;27:443–8.View ArticlePubMedGoogle Scholar
- Scully C, El Kabir M, Samaranayake LP. Candida and oral candidosis: a review. Crit Rev Oral Biol Med. 1994;5:125–57.PubMedGoogle Scholar
- Cawson RA, Binnie WH. Candida, leukoplakia and carcinoma: A possible relationship. In: Mackenzie I, Dabelsteen E, Squier CA, editors. Oral premalignancy. Proceedings of the first Dows symposium. Iowa: University of Iowa Press; 1980. p. 59–66.Google Scholar
- Russell C, Jones JH. The histology of prolonged candidal infection of the rat’s tongue. J Oral Pathol. 1975;4:330–9.View ArticlePubMedGoogle Scholar
- Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: Catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis. 1987;8:1543–8.View ArticlePubMedGoogle Scholar
- O’Grady JF, Reade PC. Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis. 1992;13:783–6.View ArticlePubMedGoogle Scholar